...
首页> 外文期刊>Prenatal Diagnosis >Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
【24h】

Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.

机译:唐氏综合征的中期妊娠产前筛查:连续妊娠中血清标志物水平之间的关联。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the association of Down syndrome screening results in successive pregnancies, and assess the impacts of including previous screening results in the current risk estimation on screening performance. METHODS: The study was based on 56,951 women who had triple marker screening in two or more singleton pregnancies in the Ontario Maternal Serum Screening (MSS) program between October 1993 and September 2000. The problem of recurrent false positive results was examined by comparing screening results from different pregnancies in the same individuals. Between-pregnancy associations in the levels of serum markers were estimated using correlation analysis. A published method was used to adjust current risk estimation for previous screening results. The effect of this adjustment was assessed by comparing screening performances prior and subsequent to the adjustment. RESULTS: The observed false positive rate (FPR) in subsequent pregnancies was 2.5 times higher than that expected (26.4% vs 10.7%) among women who screened positive in one previous pregnancy, and 3.9 times higher (47.4% vs 12.1%) among women who screened positive in two previous pregnancies. Adjusting for a previous screening result will significantly reduce the recurrent FPR without compromising detection. CONCLUSION: Risk estimation for Down syndrome may be adjusted using the screening result from a previous pregnancy.
机译:目的:探讨唐氏综合症筛查结果与连续妊娠的相关性,并评估将先前筛查结果纳入当前风险评估中对筛查表现的影响。方法:这项研究基于1993年10月至2000年9月在安大略省孕产妇血清筛查(MSS)计划中两次或多次单胎妊娠中进行三重标记筛查的56,951名妇女。通过比较筛查结果,检查了反复出现假阳性结果的问题。来自同一个人的不同怀孕。使用相关分析评估了血清标志物水平之间的孕前关联。使用一种已发布的方法来调整以前筛查结果的当前风险估计。通过比较调整前后的筛选效果来评估此调整的效果。结果:在随后一次怀孕中观察到的假阳性率(FPR)比先前怀孕筛查阳性的女性高出预期的2.5倍(26.4%比10.7%),并且比女性高3.9倍(47.4%比12.1%)在先前的两次怀孕中筛查阳性。调整先前的筛查结果将显着降低复发性FPR,而不会影响检测。结论:唐氏综合症的风险评估可使用先前妊娠的筛查结果进行调整。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号